title: Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
abstract: BACKGROUND
  Apoptosis plays a key role in cell death observed in neurodegenerative diseases marked by a progressive loss of neurons as seen in Alzheimer's disease. Although the exact cause of apoptosis is not known, a number of factors such as free radicals, insufficient levels of nerve growth factors and excessive levels of glutamate have been implicated. We and others, have previously reported that in a stable HT22 neuronal cell line, glutamate induces apoptosis as indicated by DNA fragmentation and up- and down-regulation of Bax (pro-apoptotic), and Bcl-2 (anti-apoptotic) genes respectively. Furthermore, these changes were reversed/inhibited by estrogens. Several lines of evidence also indicate that a family of cysteine proteases (caspases) appear to play a critical role in neuronal apoptosis. The purpose of the present study is to determine in primary cultures of cortical cells, if glutamate-induced neuronal apoptosis and its inhibition by estrogens involve changes in caspase-3 protease and whether this process is mediated by Fas receptor and/or mitochondrial signal transduction pathways involving release of cytochrome c.
  
  
  RESULTS
  In primary cultures of rat cortical cells, glutamate induced apoptosis that was associated with enhanced DNA fragmentation, morphological changes, and up-regulation of pro-caspase-3. Exposure of cortical cells to glutamate resulted in a time-dependent cell death and an increase in caspase-3 protein levels. Although the increase in caspase-3 levels was evident after 3 h, cell death was only significantly increased after 6 h. Treatment of cells for 6 h with 1 to 20 mM glutamate resulted in a 35 to 45% cell death that was associated with a 45 to 65% increase in the expression of caspase-3 protein. Pretreatment with caspase-3-protease inhibitor z-DEVD or pan-caspase inhibitor z-VAD significantly decreased glutamate-induced cell death of cortical cells. Exposure of cells to glutamate for 6 h in the presence or absence of 17beta-estradiol or Delta8, 17beta-estradiol (10 nM-10 microM) resulted in the prevention of cell death and was associated with a significant dose-dependent decrease in caspase-3 protein levels, with Delta8, 17beta-E2 being more potent than 17beta-E2. Protein levels of Fas receptor remained unchanged in the presence of glutamate. In contrast, treatment with glutamate induced, in a time-dependent manner, the release of cytochrome c into the cytosol. Cytosolic cytochrome c increased as early as 1.5 h after glutamate treatment and these levels were 5 fold higher after 6 h, compared to levels in the untreated cells. Concomitant with these changes, the levels of cytochrome c in mitochondria decreased significantly. Both 17beta-E2 and Delta8, 17beta-E2 reduced the release of cytochrome c from mitochondria into the cytosol and this decrease in cytosolic cytochrome c was associated with inhibition of glutamate-induced cell death.
  
  
  CONCLUSIONS
  In the primary cortical cells, glutamate-induced apoptosis is accompanied by up-regulation of caspase-3 and its activity is blocked by caspase protease inhibitors. These effects of glutamate on caspase-3 appear to be independent of changes in Fas receptor, but are associated with the rapid release of mitochondrial cytochrome c, which precedes changes in caspase-3 protein levels leading to apoptotic cell death. This process was differentially inhibited by estrogens with the novel equine estrogen Delta8, 17beta-E2 being more potent than 17beta-E2. To our knowledge, this is the first study to demonstrate that equine estrogens can prevent glutamate-induced translocation of cytochrome c from mitochondria to cytosol in rat primary cortical cells.
authors.affiliation: Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada. ymzhang@hotmail.com <ymzhang@hotmail.com>
authors.forename: YueMei
authors.initials: Y
authors.lastname: Zhang
authors.forename: Bhagu R
authors.initials: BR
authors.lastname: Bhavnani
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000187:drug effects* / Q000201:enzymology; D045304:Cytochromes c / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D018698:Glutamic Acid / Q000633:toxicity*; D006736:Horses; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004791:Enzyme Inhibitors; D004967:Estrogens; D018698:Glutamic Acid; D045304:Cytochromes c; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases
references.citation: Nature. 1996 Apr 25;380(6576):723-6
references.pmid: 8614469
references.citation: J Soc Gynecol Investig. 2003 Jul;10(5):302-8
references.pmid: 12853093
references.citation: Cell. 1996 Jul 12;86(1):147-57
references.pmid: 8689682
references.citation: Neuroreport. 1996 Sep 2;7(13):2071-7
references.pmid: 8930961
references.citation: Endocrinology. 1997 Jan;138(1):101-6
references.pmid: 8977391
references.citation: Fertil Steril. 1997 Jan;67(1):57-62
references.pmid: 8986684
references.citation: Adv Neurol. 1997;72:95-101
references.pmid: 8993688
references.citation: EMBO J. 1997 May 15;16(10):2794-804
references.pmid: 9184224
references.citation: J Biol Chem. 1997 Aug 15;272(33):20317-20
references.pmid: 9252332
references.citation: EMBO J. 1997 Aug 1;16(15):4639-49
references.pmid: 9303308
references.citation: J Soc Gynecol Investig. 2000 May-Jun;7(3):175-83
references.pmid: 10865186
references.citation: J Biol Chem. 2000 Sep 29;275(39):30586-96
references.pmid: 10859318
references.citation: J Biol Chem. 2000 Nov 24;275(47):37159-66
references.pmid: 10980192
references.citation: Cell Mol Life Sci. 2001 Apr;58(4):636-44
references.pmid: 11361096
references.citation: FEBS Lett. 2001 May 18;497(1):1-5
references.pmid: 11376653
references.citation: J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):473-82
references.pmid: 12943738
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4130-5
references.pmid: 15024130
references.citation: BMC Neurosci. 2003 Dec 23;4:32
references.pmid: 14693041
references.citation: Neurosci Lett. 2004 Sep 16;368(1):87-91
references.pmid: 15342140
references.citation: J Neurochem. 1984 Jan;42(1):1-11
references.pmid: 6139418
references.citation: Cell. 1991 Jul 26;66(2):233-43
references.pmid: 1713127
references.citation: J Clin Endocrinol Metab. 1993 Oct;77(4):1095-7
references.pmid: 8408459
references.citation: Science. 1993 Oct 29;262(5134):689-95
references.pmid: 7901908
references.citation: N Engl J Med. 1994 Mar 3;330(9):613-22
references.pmid: 7905600
references.citation: Prog Brain Res. 1994;100:47-51
references.pmid: 7938533
references.citation: Brain Res. 1994 Jul 25;652(1):169-73
references.pmid: 7953717
references.citation: J Biol Chem. 1994 Dec 9;269(49):30761-4
references.pmid: 7983002
references.citation: Science. 1995 Mar 10;267(5203):1445-9
references.pmid: 7878463
references.citation: Science. 1995 Mar 10;267(5203):1456-62
references.pmid: 7878464
references.citation: Nature. 1995 May 4;375(6526):78-81
references.pmid: 7536900
references.citation: Nature. 1995 May 4;375(6526):81-3
references.pmid: 7536901
references.citation: Cell. 1995 Jun 2;81(5):801-9
references.pmid: 7774019
references.citation: Nature. 1995 Jul 6;376(6535):37-43
references.pmid: 7596430
references.citation: Cell. 1995 Aug 11;82(3):349-52
references.pmid: 7634323
references.citation: Neurochem Int. 1994 May;24(5):485-93
references.pmid: 7647702
references.citation: Biochem Biophys Res Commun. 1995 Nov 13;216(2):473-82
references.pmid: 7488136
references.citation: EMBO J. 1995 Dec 15;14(24):6148-56
references.pmid: 8557034
references.citation: J Biol Chem. 1996 Jan 26;271(4):1841-4
references.pmid: 8567626
references.citation: J Neurosci Res. 1995 Dec;42(5):674-83
references.pmid: 8600300
references.citation: EMBO J. 1996 Mar 1;15(5):1012-20
references.pmid: 8605870
references.citation: Biochem J. 1997 Aug 15;326 ( Pt 1):1-16
references.pmid: 9337844
references.citation: Cell. 1997 Nov 14;91(4):479-89
references.pmid: 9390557
references.citation: EMBO J. 1998 Jan 2;17(1):37-49
references.pmid: 9427739
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4997-5002
references.pmid: 9560217
references.citation: Free Radic Biol Med. 1998 Jun;24(9):1375-89
references.pmid: 9641255
references.citation: Genes Cells. 1998 May;3(5):297-306
references.pmid: 9685181
references.citation: J Biol Chem. 1998 Oct 9;273(41):26566-70
references.pmid: 9756894
references.citation: Brain Res. 1998 Nov 9;810(1-2):87-92
references.pmid: 9813255
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14681-6
references.pmid: 9843949
references.citation: Cell Death Differ. 1998 Dec;5(12):1004-16
references.pmid: 9894607
references.citation: Biochem Biophys Res Commun. 1999 Mar 16;256(2):381-4
references.pmid: 10079193
references.citation: J Neurochem. 1999 Apr;72(4):1552-63
references.pmid: 10098861
references.citation: Eur J Neurosci. 1999 Mar;11(3):1067-72
references.pmid: 10103099
references.citation: Cell. 1999 Apr 30;97(3):395-406
references.pmid: 10319819
references.citation: J Neurochem. 1999 Jun;72(6):2601-9
references.pmid: 10349872
references.citation: J Soc Gynecol Investig. 2001 Jul-Aug;8(4):245-54
references.pmid: 11525901
references.citation: Br J Pharmacol. 2001 Nov;134(6):1263-70
references.pmid: 11704646
references.citation: Menopause. 2001 Nov-Dec;8(6):408-19
references.pmid: 11723413
references.citation: J Neurochem. 2002 Jan;80(2):207-18
references.pmid: 11902111
references.citation: FEBS Lett. 2002 Jun 19;521(1-3):53-6
references.pmid: 12067725
references.citation: J Neurosci. 2002 Sep 1;22(17):7650-61
references.pmid: 12196588
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2842-7
references.pmid: 12604781
references.citation: J Biol Chem. 1996 Jul 12;271(28):16720-4
references.pmid: 8663294